The Medicines and Healthcare products Regulatory Agency (MHRA) has announced a fundamental change to its fee model for medical device registration under the Devices Online Registration System (DORS). This transition is critical for all manufacturers, UK Responsible Persons, and entities maintaining registrations in the UK market.
Regulatory professionals must take action to align their compliance strategies and update their device portfolios ahead of the implementation date. Here is a summary of key changes, as specified by the MHRA:
- New annual fee: This replaces the current one-off application fee and supports ongoing surveillance and regulatory activity.
- Letters of Designation: From 1 April 2026, UK Responsible Persons (UKRPs) and Northern Ireland Authorised Representatives will no longer need to pay a separate fee to upload new Letters of Designation for their represented manufacturers. The current statutory fee will apply until 31 March 2026.
- Updates to organisation name and/or address: From 1 April 2026, you will no longer need to pay a fee to update your organisation’s name or address. The current statutory fee will apply until 31 March 2026.
The shift to an annual fee structure is primarily driven by the need to secure sustainable funding to deliver the strengthened safety and surveillance system for medical devices in the UK. Specifically, the reasons are:
- Funding Strengthened Regulatory Function: The introduction of the annual fee is intended to provide the necessary resources to effectively deliver the enhanced regulatory functions mandated by the new post-market surveillance legislation (SI 2024 No.1368).
- Improved Patient Safety and Vigilance: The funding supports the enhanced ability to quickly respond to performance and safety signals, which is a core objective of the new legislation.
- Support for Strategic Regulatory Goals: The funding model ensures the MHRA can implement a regulatory approach that is both risk-proportionate and pro-innovation, aligning with broader policy objectives, such as those outlined in the NHS 10-year plan.
The Shift: From One-Off Application to Annual Categorical Fees
Historically, the MHRA charged a single, one-off fee upon the initial registration of a medical device or IVD. The new framework introduces an annual, recurring fee structure that will apply to all active registrations. Effective 1 April, 2026, this new annual fee will be calculated not per individual registered device, but per GMDN® Level 2 Category under which the devices are registered. It is currently estimated to cost £300 per year, per Level 2 GMDN® Category.
| Feature | Explanation of Calculation | Impact on Fees |
| Primary Basis for Fee | The fee is calculated per Device Function GMDN® Level 2 Category under which your devices are registered. | You are charged once per distinct Level 2 Category, regardless of the number of individual devices or GMDN Codes you have within that category. |
| Single Charge per GMDN® Code | If a specific GMDN Code and Term appear across multiple Level 2 Categories in your registration, you will only be charged once for it. | Prevents duplicate billing for a single, highly specific device description. |
| Handling ‘Overlaps’ and Minimisation | The MHRA will actively review your registrations to ensure you are charged for the fewest possible GMDN® Categories. If a device’s GMDN Code falls into multiple potential Level 2 Categories (an overlap), the system will assign the device to the Category with the most existing GMDN entries you have registered. | This is a mechanism to actively reduce your overall annual fee liability by consolidating charges into the largest possible categories. |
| Level 1 Categories | For those instances where a GMDN Code only exists at Level 1 (the broadest category level), a single fee will apply to all GMDN Codes you hold within that particular Level 1 Category. | Ensures all devices are covered, even if they lack a specific Level 2 grouping. |
In essence, the new system is designed to charge a single annual fee for each broad functional area of devices you manufacture and register, actively employing rules to prevent overcharging by consolidating your registered GMDN codes into the minimal number of chargeable categories.
DORS Cleanup
To ensure accurate fee assessment and prevent unnecessary costs, the MHRA has imposed a mandatory data hygiene exercise for all DORS registrants.
Mandatory Review and Deregistration
All registrants are required to review their entire device portfolio within DORS and unregister all obsolete, inactive, or historical devices that are no longer being placed on the UK market. This includes:
- Devices that have been discontinued or withdrawn.
- Devices that have been replaced by newer models.
- Devices that were registered but never placed on the market in the UK.
The Deadline: March 30, 2026, 5:00 PM
The window for this mandatory cleanup closes strictly at 5:00 PM on March 30, 2026.
All registrations active in DORS at this cutoff point will be used to calculate the initial annual fee bill based on the associated GMDN Level 2 Categories.
Consequences of Non-Compliance
Regulatory professionals are strongly advised to meet the cleanup deadline to mitigate significant compliance and financial risks:
- Overpayment and Inaccurate Billing: Failure to unregister obsolete devices will result in the MHRA including those devices’ GMDN categories in the annual fee calculation, leading to unjustified and unnecessary annual charges.
- Regulatory Sanctions: The MHRA has indicated that failure to comply with the new fee structure (including non-payment resulting from an incorrect/inflated registration count) could lead to severe actions, including closure or suspension of the registrant’s DORS account. Loss of account access means a regulatory inability to place devices on the UK market.
Next Steps for Regulatory Teams
To prepare for this major transition, regulatory professionals should initiate the following process immediately:
- Portfolio Audit: Generate a complete list of all active and historical device registrations from the DORS platform.
- Commercial Verification: Cross-reference the DORS list with current commercial data to identify every device that is no longer being placed on the UK market.
- Deregistration Execution: Systematically process the deregistration of all obsolete devices in DORS well in advance of the March 30, 2026, deadline.
- GMDN Categorisation Review: Verify and document the GMDN® Level 2 Category for every remaining active device to accurately project future annual fee liability.
This fee restructuring represents a new level of commitment to maintaining an accurate and current device database within the UK. Proactive compliance is essential to ensure continued market access and manage regulatory operating costs effectively.
How Specculo Can Assist
The complexity of the DORS cleanup, the transition to a cost-per-category model, and the implementation of new PMS requirements demand specialised regulatory expertise. Specculo is positioned to provide critical support to manufacturers navigating this transition, ensuring continuity of market access and cost control.
Our UK-RP Service: For non-UK manufacturers, the new annual fee structure increases the importance of a compliant and proactive UK RP. Specculo acts as your designated UK RP, registration and fee management, vigilance and compliance oversight.
DORS Portfolio Remediation: We can conduct a comprehensive review of your entire DORS registry to ensure that this reflects your existing portfolio on the UK market and deregister inactive products.
See the full MHRA guidance here.